In the fully adjusted model V, patients with hs-CRP values in Q3 had a 33% [sub-distributional Hazard Ratio (sHR): 1.33, 95% CI: 1.00–1.76] and in Q4 had a 80% (sHR: 1.80, 95% CI: 1.37–2.36) increased risk of HF post-discharge compared with patients in Q1 (p trend < 0.001). The gene discussed is CRP; the disease is hydrops fetalis.